Home/Filings/4/0001181431-12-036818
4//SEC Filing

MCMULLIN KIRK 4

Accession 0001181431-12-036818

CIK 0000930553other

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 5:00 PM ET

Size

38.5 KB

Accession

0001181431-12-036818

Insider Transaction Report

Form 4
Period: 2012-06-06
MCMULLIN KIRK
VP, Operations
Transactions
  • Disposition to Issuer

    Common Stock

    2012-06-06$9.10/sh122,339$1,113,2850 total
  • Disposition to Issuer

    Option (right to buy)

    2012-06-06100,0000 total
    Exercise: $3.75Exp: 2021-11-30Common Stock (100,000 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-068,6090 total
    Exercise: $6.82Exp: 2021-02-07Common Stock (8,609 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-066,5640 total
    Exercise: $1.04Exp: 2019-02-03Common Stock (6,564 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-0679,2330 total
    Exercise: $3.49Exp: 2012-12-16Common Stock (79,233 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-0618,3110 total
    Exercise: $4.46Exp: 2018-02-08Common Stock (18,311 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-069,5740 total
    Exercise: $10.27Exp: 2015-02-17Common Stock (9,574 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-0613,4260 total
    Exercise: $10.27Exp: 2015-02-17Common Stock (13,426 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-0628,0770 total
    Exercise: $9.41Exp: 2014-02-05Common Stock (28,077 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-061,9230 total
    Exercise: $9.41Exp: 2014-02-05Common Stock (1,923 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-0625,1890 total
    Exercise: $6.82Exp: 2021-02-07Common Stock (25,189 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-067,2910 total
    Exercise: $3.63Exp: 2020-02-02Common Stock (7,291 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-0616,0400 total
    Exercise: $1.04Exp: 2019-02-03Common Stock (16,040 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-0616,4290 total
    Exercise: $7.43Exp: 2017-02-02Common Stock (16,429 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-0618,4270 total
    Exercise: $6.77Exp: 2016-02-16Common Stock (18,427 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-0615,3140 total
    Exercise: $3.63Exp: 2020-02-02Common Stock (15,314 underlying)
Footnotes (16)
  • [F1]Disposed of pursuant to agreement and plan of Merger Agreement by and among the Company, Bausch & Lomb Incorporated and Inga Acquisition Corporation, as amended (the "Merger Agreement") in exchange for $9.10 per share, without interest, less any applicable withholding tax, on the effective date of the merger.
  • [F10]The option which was fully vested on 2/02/09 was cancelled in the Merger Agreement in exchange for a cash payment equal to $1.67 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F11]The option which was fully vested on 2/17/09 was cancelled in the Merger Agreement in exchange for a cash payment equal to $2.33 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F12]The option which was fully vested on 12/16/06 was cancelled in the Merger Agreement in exchange for a cash payment equal to $5.61 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F13]The option which was fully vested on 02/17/09 was cancelled in the Merger Agreement.
  • [F14]The option which was fully vested on 12/17/07 was cancelled in the Merger Agreement.
  • [F15]The option which was fully vested on 02/05/08 was cancelled in the Merger Agreement.
  • [F16]The option which was fully vested on 12/05/06 was cancelled in the Merger Agreement.
  • [F2]The option which was unvested was cancelled in the Merger Agreement in exchange for a cash payment equal to $5.35 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F3]The option of which 1,109 shares were unvested and 7,500 shares were vested was cancelled in the Merger Agreement in exchange for a cash payment equal to $2.28 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F4]The option which was unvested was cancelled in the Merger Agreement in exchange for a cash payment equal to $2.28 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F5]The option which was fully vested on 12/02/10 was cancelled in the Merger Agreement in exchange for a cash payment equal to $5.47 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F6]The option which was unvested was cancelled in the Merger Agreement in exchange for a cash payment equal to $5.47 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F7]The option which was unvested was cancelled in the Merger Agreement in exchange for a cash payment equal to $8.06 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F8]The option which was fully vested on 12/3/10 was cancelled in the Merger Agreement in exchange for a cash payment equal to $8.06 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F9]The option which was fully vested on 12/08/10 was cancelled in the Merger Agreement in exchange for a cash payment equal to $4.64 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).

Issuer

ISTA PHARMACEUTICALS INC

CIK 0000930553

Entity typeother

Related Parties

1
  • filerCIK 0001216985

Filing Metadata

Form type
4
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 5:00 PM ET
Size
38.5 KB